Double Bond Pharmaceutical is a distributor of Inofer in Russia and Belarus
Last year, Double Bond Pharmaceutical and Laboratoire XO signed a distribution agreement for Inofer in Sweden, Norway, Denmark and Finland. Now Double Bond Pharmaceutical has the distribution rights for Russia and Belarus as well. Inofer is an iron supplement consisting of ferrous succinate which is a chemical iron form known to be more readily absorbed into the body of people with impaired iron uptake. According to WHO, "iron deficiency is the most common and widespread nutritional disorder in the world". Inofer is registered in France. The results of DBP's clinical trial of Inofer showed